Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
BMC Psychiatry ; 24(1): 586, 2024 Aug 28.
Artículo en Inglés | MEDLINE | ID: mdl-39198722

RESUMEN

Lithium Carbonate is an effective treatment for affective disorders, but has a range of side effects. This case report highlights a rare side effect of Raynaud's phenomenon following initiation of Lithium therapy in a patient with recurrent depressive disorder. He was commenced on Lithium therapy to treat severe treatment resistant depression with psychotic symptoms when alternative treatments trialled were ineffective. He had no other risk factors or known aetiological causes for development of Raynaud's phenomenon. Symptoms resolved on discontinuation of Lithium and re-emerged on recommencement. Previous case series have shown Lithium effectively treating vasospastic disorders such as cluster headache and Raynaud's phenomenon. However, a paradoxical reaction to those previously described was induced in this case.


Asunto(s)
Carbonato de Litio , Enfermedad de Raynaud , Humanos , Masculino , Antimaníacos/administración & dosificación , Antimaníacos/efectos adversos , Trastorno Depresivo Resistente al Tratamiento/tratamiento farmacológico , Carbonato de Litio/administración & dosificación , Carbonato de Litio/efectos adversos , Enfermedad de Raynaud/inducido químicamente
2.
Eur Psychiatry ; 19(3): 159-63, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15158923

RESUMEN

Schizophrenia is associated with altered neural development. We assessed neurological soft signs (NSS) and dermatoglyphic anomalies (total a-b ridge count (TABRC) and total finger ridge count) in 15 pairs of twins concordant and discordant for schizophrenia. Within-pair differences in both NSS and TABRC scores were significantly greater in discordant compared to concordant monozygotic pairs. There was no significant difference in NSS and TABRC scores between subjects with schizophrenia and their co-twins without the illness. However, monozygotic discordant twins with schizophrenia had higher ABRCs on their right hands compared to their co-twins without the illness. These findings suggest that an unidentified environmental event acting between weeks 6 and 15 of gestation affects the development of monozygotic twins who go on to develop schizophrenia but does not have a corresponding effect on their co-twins who do not develop the illness. The effect of such an event on dermatoglyphic profiles appears lateralised to the right hand in affected twins.


Asunto(s)
Encéfalo/fisiopatología , Dermatoglifia , Esquizofrenia/epidemiología , Esquizofrenia/fisiopatología , Gemelos/estadística & datos numéricos , Adulto , Femenino , Humanos , Masculino , Esquizofrenia/diagnóstico , Índice de Severidad de la Enfermedad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA